Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference

Prostate

Volumn 71, Issue 13, 2011, Pages 1390-1400

  Xu, Tong ^a   He, Kaijie ^a   Wang, Lina ^b   Goldkorn, Amir ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cancer progenitor cell; cancer stem cell; prostate cancer; telomerase targeting

Indexed keywords

HERMES ANTIGEN; SMALL INTERFERING RNA; TELOMERASE; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CELL PROLIFERATION; CELL SUBPOPULATION; CLONOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE TUMOR; PROSTATECTOMY; PROTEIN FUNCTION; RNA INTERFERENCE; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD44; HUMANS; INTEGRIN ALPHA2BETA1; MALE; MICE; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TELOMERASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80051664954     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21355     Document Type: Article

References (45)

1. Gupta PB, Chaffer CL, Weinberg RA,. Cancer stem cells: Mirage or reality? Nat Med 2009; 15 (9): 1010-1012.
2. Visvader JE, Lindeman GJ,. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8 (10): 755-768.
3. Collins AT, Habib FK, Maitland NJ, Neal DE,. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001; 114 (Pt 21): 3865-3872. (Pubitemid 33094701)
4. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ,. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65 (23): 10946-10951. (Pubitemid 41713363)
5. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C, Schultz PG, Reddy VA,. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 2009; 106 (1): 268-273.
6. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL,. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008; 98 (4): 756-765. (Pubitemid 351272625)
7. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG,. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25 (12): 1696-1708.
8. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS,. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 2007; 67 (7): 3153-3161. (Pubitemid 46724852)
9. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT,. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008; 68 (23): 9703-9711.
10. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL,. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 2009; 26 (5): 433-446.
11. Brown MD, Gilmore PE, Hart CA, Samuel JD, Ramani VA, George NJ, Clarke NW,. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 2007; 67 (13): 1384-1396. (Pubitemid 47435786)
12. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG,. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008; 68 (6): 1820-1825. (Pubitemid 351416567)
13. Marian CO, Wright WE, Shay JW,. The effects of telomerase inhibition on prostate tumor-initiating cells. Int J Cancer 2010; 127 (2): 321-331.
14. Liao CP, Adisetiyo H, Liang M, Roy-Burman P,. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 2010; 70 (18): 7294-7303.
15. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H,. Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 2009; 69 (22): 8555-8562.
16. Cunha GR, Sekkingstad M, Meloy BA,. Heterospecific induction of prostatic development in tissue recombinants prepared with mouse, rat, rabbit and human tissues. Differentiation 1983; 24 (2): 174-180. (Pubitemid 13010767)
17. Guzman-Ramirez N, Voller M, Wetterwald A, Germann M, Cross NA, Rentsch CA, Schalken J, Thalmann GN, Cecchini MG,. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 2009; 69 (15): 1683-1693.
18. Maitland NJ, Collins AT,. Prostate cancer stem cells: A new target for therapy. J Clin Oncol 2008; 26 (17): 2862-2870.
19. Goldkorn A, Blackburn EH,. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Cancer Res 2006; 66 (11): 5763-5771. (Pubitemid 43927130)
20. Shay JW, Wright WE,. Telomerase therapeutics for cancer: Challenges and new directions. Nat Rev Drug Discov 2006; 5 (7): 577-584. (Pubitemid 43971192)
21. Xu T, Lu B, Tai YC, Goldkorn A,. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res 2010; 70 (16): 6420-6426.
22. Xu T, Xu Y, Liao CP, Lau R, Goldkorn A,. Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo. Mol Cancer Ther 2010; 9 (2): 438-449.
23. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW,. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18 (2): 173-179. (Pubitemid 26116862)
24. Gu G, Yuan J, Wills M, Kasper S,. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67 (10): 4807-4815. (Pubitemid 46910189)
25. Shay JW, Bacchetti S,. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33 (5): 787-791.
26. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB, Popescu NC, Weinberg RA,. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 2002; 99 (20): 12606-12611.
27. Mimeault M, Batra SK,. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Ageing Res Rev 2009; 8 (2): 94-112.
28. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON,. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 2010; 70 (5): 491-501.
29. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG,. Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67 (14): 6796-6805. (Pubitemid 47105527)
30. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, Cunha GR, Blackburn EH,. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 2004; 64 (14): 4833-4840. (Pubitemid 38924527)
31. Marie-Egyptienne DT, Brault ME, Nimmo GA, Londono-Vallejo JA, Autexier C,. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA. Cancer Lett 2009; 275 (2): 266-276.
32. Wagner W, Ansorge A, Wirkner U, Eckstein V, Schwager C, Blake J, Miesala K, Selig J, Saffrich R, Ansorge W, Ho AD,. Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 2004; 104 (3): 675-686. (Pubitemid 38970560)
33. Herbert BS, Hochreiter AE, Wright WE, Shay JW,. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc 2006; 1 (3): 1583-1590.
34. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE,. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279 (5349): 349-352. (Pubitemid 28063364)
35. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA,. Creation of human tumour cells with defined genetic elements. Nature 1999; 400 (6743): 464-468. (Pubitemid 29361801)
36. Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW, DePinho RA, Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392 (6676): 569-574. (Pubitemid 28207706)
37. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, Artandi SE,. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436 (7053): 1048-1052. (Pubitemid 41191691)
38. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM,. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461 (7263): 495-500.
39. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON,. Identification of a cell of origin for human prostate cancer. Science 2010; 329 (5991): 568-571.
40. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100 (7): 3983-3988. (Pubitemid 36418143)
41. O'Brien CA, Kreso A, Dick JE,. Cancer stem cells in solid tumors: An overview. Semin Radiat Oncol 2009; 19 (2): 71-77.
42. O'Brien CA, Pollett A, Gallinger S, Dick JE,. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445 (7123): 106-110. (Pubitemid 46067310)
43. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ,. Efficient tumour formation by single human melanoma cells. Nature 2008; 456 (7222): 593-598.
44. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB,. Identification of human brain tumour initiating cells. Nature 2004; 432 (7015): 396-401. (Pubitemid 39551674)
45. Hao JL, Cozzi PJ, Khatri A, Power CA, Li Y,. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Curr Cancer Drug Targets 2010; 10 (3): 287-306.